Expert Opinion on Drug Discovery, 1746-0441

Journal

View graph of relations

Related Publications
  1. New directions in antimalarial target validation

    Batista, F. A., Gyau, B., Vilacha, J. F., Bosch, S. S., Lunev, S., Wrenger, C. & Groves, M. R., 1-Feb-2020, In : Expert Opinion on Drug Discovery. 15, 2, p. 189-202 14 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

  2. How does a researcher choose the best rodent model for their Alzheimer's disease drug discovery study?

    Van Dam, D. & De Deyn, P. P., 8-Oct-2019, In : Expert Opinion on Drug Discovery. 3 p.

    Research output: Contribution to journalEditorialAcademicpeer-review

  3. PROTACs- a game-changing technology

    Konstantinidou, M., Li, J., Zhang, B., Wang, Z., Shaabani, S., Ter Brake, F., Essa, K. & Dömling, A., 2019, In : Expert Opinion on Drug Discovery. 14, 12, p. 1255-1268 14 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Merits and complexities of modeling multiple sclerosis in non-human primates: Implications for drug discovery

    't Hart, B. A., Laman, J. D. & Kap, Y. S., 2018, In : Expert Opinion on Drug Discovery. 13, 5, p. 387-397 11 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

  5. Non human primate models for Alzheimer's disease-related research and drug discovery

    Van Dam, D. & De Deyn, P. P., 2017, In : Expert Opinion on Drug Discovery. 12, 2, p. 187-200 14 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

View all (9) »

ID: 2407207